← Regulatory Affairs
The approved label as the source of claims
Medical content references the approved label directly, so when the label changes the responses and materials built on it surface for review.
Every claim traces to the approved label
Medical information responses, promotional review, and scientific content all rest on the same source: what the label says and what the evidence supports. When those live in separate documents, answers drift and claims outrun the data. Krevyos holds medical content against the label and the evidence it comes from, so what the team says stays tied to what was approved.
- Domain owner
- Medical Director · Medical Information · Medical Reviewer
- Activities
- Medical information · Promotional review · Publications · Field medical · Congress
- Standards
- GPP 2022 · ICMJE · PhRMA Code · Local promotional codes
Capabilities
Medical information request handling
Inbound medical questions answered from standard response documents that are versioned against the current label, so an answer is never built on superseded information.
- Standard response docs
- Med info SLAs
Medical review of promotional and non-promotional material
Claims reviewed against the approved label and the evidence behind them, with the review trail held alongside the material rather than in a separate approval inbox.
- MLR review
- Promotional compliance
Scientific content and publications per GPP 2022
Publication planning, authorship, and disclosures tracked as a record rather than a project folder, so good publication practice is a property of the work.
- Publication planning
- GPP 2022
Field medical and KOL engagement records
Medical science liaison activity and expert engagements captured as part of the operation, so interactions and their follow-ups are visible rather than scattered across calendars.
- MSL activity
- Engagement logs
Evidence library and congress dossiers
The evidence supporting each claim held in one library, so a congress dossier or a response document is assembled from sources that are already vetted.
- Evidence library
- Congress dossiers
Touchpoints
← Labeling
Label content and safety statements
Medical information draws on the same label content the labeling operation maintains, so an answer and the leaflet it quotes never diverge.
← Pharmacovigilance
Safety signals inform medical content
A new safety finding reaches the responses and materials that touch it, so medical information reflects the current safety picture rather than last quarter's.
← Clinical Bioequivalence
Bioequivalence data as evidence
Bioequivalence results feed the evidence library, so scientific content and enquiry responses draw on the study record rather than a re-description of it.
→ Market Access
Evidence for value dossiers
The evidence library feeds value and access dossiers, so the medical and commercial views of a product are built from the same sources.
Outcomes
- −50%(indicative)
Time to answer a medical information request
Responses are assembled from label-linked standard documents rather than drafted from scratch, so a medical enquiry is answered in a fraction of the time.
- 100%(indicative)
Medical responses traceable to the approved label
Every answer points back to the label and evidence it rests on, so a response is never an untraceable assertion.
Claims outrunning the evidence
Review holds each claim against its source, so a statement without support is caught before it reaches an audience.
- +3×(indicative)
Reuse of scientific content across markets
Vetted content carries across markets with its evidence attached, so a response built once serves many territories rather than being rewritten for each.
Figures marked indicative are directional benchmarks against comparable generics operations; per-customer numbers replace them in working sessions.
Want to talk?
Same foundation under every service. A conversation usually clarifies where to start.